Skip to content

Clinical trials

Phase 2 Congenital Abnormalities trials in the United States

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Congenital Abnormalities Phase: Phase 2 Country / region: United States Clear all

134 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20003
20016
20028
20034
200412
20058
200615
20079
200811
20097
20108
20117
20123
20135
20146
20151
20171
20212

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed96
Terminated30
Unknown status3
Withdrawn3
Active, not recruiting2

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Fred Hutchinson Cancer Center26
National Cancer Institute (NCI)22
Case Comprehensive Cancer Center11
Roswell Park Cancer Institute7
Masonic Cancer Center, University of Minnesota5
City of Hope Medical Center4
Memorial Sloan Kettering Cancer Center4
Northside Hospital, Inc.4
SWOG Cancer Research Network4
Alliance for Clinical Trials in Oncology3

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Congenital Abnormalities134
Leukemia, Myeloid, Acute113
Leukemia66
Precursor Cell Lymphoblastic Leukemia-Lymphoma56
Leukemia, Lymphocytic, Chronic, B-Cell50
Myeloproliferative Disorders50
Leukemia, Myeloid, Accelerated Phase49
Myelodysplastic Syndromes48
Lymphoma, Follicular47
Leukemia, Myeloid, Chronic-Phase46

Trials

Showing 1 to 25 of 134. Each trial links to its page on Pharma Observatory.

34 more trials match. See them on Pharma Observatory

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.